EU · EudraLex Vol.4
EU GMP Annex 1 9.37
9. Environmental & process monitoring › Aseptic process simulation (APS) (also known as media fill)
Section text
For sterile active substances, batch size should be large enough to represent routine operation, simulate intervention operation at the worst case, and cover all surfaces that may come into contact with the sterile product. In addition, all the simulated materials (surrogates or growth medium) should be subjected to microbial evaluation. The simulation materials should be sufficient to satisfy the evaluation of the process being simulated and should not compromise the recovery of micro-organisms.
Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15